Table 8.
Preclinical studies of caffeine-mediated neuroprotective effects.
Model | CAF-Mediated Protective Effects | Proposed Mechanisms Involved | Up/Down | References |
---|---|---|---|---|
In vivo | ||||
THY-Tau22 Transgenic mouse | anti-inflammatory antioxidative | TNF-α, GFAP, MAPK, Nrf2, MnSOD |
↓ ↑ |
[170] |
AD transgenic mouse model (Tg APPswe) | anti-amyloidogenic | PS1, BACE-1 | ↓ | [171] |
APP/PS1 double transgenic AD mice | anti-amyloidogenic | BDNF, TrkB | ↑ | [173] |